// App-Quantinova.ai

: EXTH-28. ENHANCING SELUMETINIB-MEDIATED KILLING OF SHH MEDULLOBLASTOMA

Researchers

Presenter

  • Brent Guppy

Principal Investigators

  • Lisa Liang

  • Chris Porter

  • Tamra Werbowetski-Ogilvie

Medical Centers

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Extracellular signal-regulated kinase

Drug/Treatment

  • selumetinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved